RLIP76 in Human Serum in Adults With Rheumatologic Diseases

Withdrawn before enrolling

Conditions studied: Carotid Atherosclerosis

In brief

It is the investigators aim to determine the feasibility of directly detecting anti-RLIP76 auto-antibodies in human serum using prepared RLIP76 antigen peptides in persons with rheumatologic disease and persons without rheumatologic diesease ("healthy subjects").

Key facts

Study ID

NCT00861159

Run by

University of North Texas Health Science Center

People needed

100

Starts

2011-09-01

Expected to finish

2011-09-01

Last updated by the study team

2011-01-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adult (age 18+), non-pregnant subjects with previously diagnosed rheumatologic disease will be candidates for the study.

You may not qualify if…

• Children, pregnant women, prisoner, persons with any medical condition that precludes phlebotomy, and patients unwilling or unable to provide consent.

Where it is running

• University of North Texas Health Science Center — Fort Worth, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.